Literature DB >> 301548

Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice.

J F Kearney, M D Cooper, J Klein, E R Abney, R M Parkhouse, A R Lawton.   

Abstract

We used immunofluorescence to examine the developmental relationship of Ia and IgD on B cells. Pre-B cells in fetal liver did not express Ia. Only very few surface IgM-positive (sIgM+) B cells in fetal spleen were found to be Ia+ and were weakly stained for Ia. After birth there was a linear increase in the proportion of sIgM+ spleen cells which expressed Ia, reaching 95% by 9 days. Adult bone marrow also contains a sizeable proportion of sIgM+ Ia- cells. Unstimulated cells from fetal or newborn liver and spleen expressed Ia at the same rate in culture. Anti-Ia antisera suppressed the LPS-induced differentiation of IgM and IgG plasma cells in cultures of neonatal lymphocytes. Ia was also detected on IgM and IgG plasma cells in vitro suggesting that lipopolysaccharide (LPS)-stimulated B cells by may express Ia antigens, induced by LPS, or appearing as part of normal differentiation. IgD did not appear on sIgM+ cells until 3 days of age and then rose slowly to reach adult levels later than Ia antigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301548      PMCID: PMC2180751          DOI: 10.1084/jem.146.1.297

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Enumeration and analysis of antibody-forming cell precursors in the neonatal mouse.

Authors:  J L Press; N R Klinman
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

2.  Early production of intracellular IgM by B-lymphocyte precursors in mouse.

Authors:  M C Raff; M Megson; J J Owen; M D Cooper
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

3.  Candidate for immunoglobulin D present on murine B lymphocytes.

Authors:  E R Abney; R M Parkhouse
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

Review 4.  The histocompatibility-linked immune response genes.

Authors:  B Benacerraf; D H Katz
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

5.  A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex.

Authors:  D H Sachs; J L Cone
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

6.  Evidence for the clonal abortion theory of B-lymphocyte tolerance.

Authors:  G J Nossal; B L Pike
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

7.  Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes.

Authors:  J A Frelinger; J E Neiderhuber; C S David; D C Shreffler
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

8.  The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.

Authors:  S K Pierce; N R Klinman
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self.

Authors:  M C Raff; J J Owen; M D Cooper; A R Lawton; M Megson; W E Gathings
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  In vitro tolerance induction of neonatal murine B cells.

Authors:  E S Metcalf; N R Klinman
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  32 in total

1.  Identification of a germ-line pro-B cell subset that distinguishes the fetal/neonatal from the adult B cell development pathway.

Authors:  Li-Sheng Lu; James Tung; Nicole Baumgarth; Ometa Herman; Michael Gleimer; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  The response to lipopolysaccharide of mouse spleen lymphocytes fractionated on the basis of surface immunoglobulin and complement receptor using fluorescence-activated cell sorting and rosetting techniques.

Authors:  D L Brandon; A J Edwards; R M Parkhouse
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

3.  Splenectomy fails to attenuate immuno-hematologic changes after rodent vertical sleeve gastrectomy.

Authors:  Alexandra R Himel; Erin B Taylor; Charles L Phillips; Bradley A Welch; Redin A Spann; Sibali Bandyopadhyay; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-18

4.  Blocking of primary in vitro antibody responses to thymus-independent and thymus-dependent antigens with antiserum specific for IgM or IgD.

Authors:  J C Cambier; F S Ligler; J W Uhr; J R Kettman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Immune deficiency due to high copy numbers of an Ak beta transgene.

Authors:  S Gilfillan; S Aiso; S A Michie; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Terminal B cell development as seen in different human myelomas and related disorders.

Authors:  G F Burns; C P Worman; B E Roberts; C G Raper; C R Barker; J C Cawley
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

7.  Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype.

Authors:  J E Alés-Martínez; G L Warner; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Human lactoferrin induces phenotypic and functional changes in murine splenic B cells.

Authors:  M Zimecki; J Mazurier; G Spik; J A Kapp
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Authors:  J L Curtis; A A Nordin
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

10.  Expression of cell surface markers after human B lymphocyte activation.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.